{"name":"S.L.A. Pharma AG","slug":"s-l-a-pharma-ag","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Diltiazem hydrochloride 4% cream","genericName":"Diltiazem hydrochloride 4% cream","slug":"diltiazem-hydrochloride-4-cream","indication":"Anal fissure pain relief (topical application)","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Eicosapentaenoic acid gastro-resistant capsules","genericName":"Eicosapentaenoic acid gastro-resistant capsules","slug":"eicosapentaenoic-acid-gastro-resistant-capsules","indication":"Hypertriglyceridemia (elevated triglycerides)","status":"phase_3"}]}],"pipeline":[{"name":"Diltiazem hydrochloride 4% cream","genericName":"Diltiazem hydrochloride 4% cream","slug":"diltiazem-hydrochloride-4-cream","phase":"phase_3","mechanism":"Diltiazem is a calcium channel blocker that reduces smooth muscle contraction and improves blood flow when applied topically to affected tissues.","indications":["Anal fissure pain relief (topical application)"],"catalyst":""},{"name":"Eicosapentaenoic acid gastro-resistant capsules","genericName":"Eicosapentaenoic acid gastro-resistant capsules","slug":"eicosapentaenoic-acid-gastro-resistant-capsules","phase":"phase_3","mechanism":"Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid that reduces triglycerides and modulates inflammatory pathways in cardiovascular disease.","indications":["Hypertriglyceridemia (elevated triglycerides)","Cardiovascular risk reduction in patients with elevated triglycerides"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPT0JpU1RNZGRlZ1NtUXl1blktcktNSDBPUGpMNDNXVWtlanBad2Jlai1iSzJ5eW81bmtabkRWRFZ4clNIY3h4cUNsYk0xa1o1ZGJrVXRNZlJfRk9VUzFXSkN0TUxQOWlDQ0wxVjB0OFphYmQ0U2FHc0dnWFNlaXNVSA?oc=5","date":"2022-04-28","type":"pipeline","source":"MedPage Today","summary":"New Guidelines Target Cancer Risk in Rare GI Syndromes - MedPage Today","headline":"New Guidelines Target Cancer Risk in Rare GI Syndromes","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}